You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Multiple Myeloma: An Expert Discussion on the Role of Cytogenetics and Minimal Residual Disease

  • Authors: Shaji Kumar, MD; Dragan Jevremovic, MD
  • CME / ABIM MOC Released: 5/25/2023
  • Valid for credit through: 5/25/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for hematologists/oncologists, pathologists, and other healthcare professionals (HCPs) involved in the care of patients with multiple myeloma (MM).

The goal of this activity is for learners to be better able to evaluate the role of genetic biomarkers and minimal residual disease (MRD) to stratify risk, assess response to therapy, and guide treatment for MM.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Disease biomarkers used in the risk stratification of MM
    • MRD assessment as a prognostic marker in MM
  • Demonstrate greater confidence in their ability to
    • Personalize treatment for patients with MM based on disease-specific characteristics


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


  • Shaji Kumar, MD

    Mark and Judy Mullins Professor of Hematologic Malignancies
    Division of Hematology
    Mayo Clinic
    Rochester, Minnesota


    Shaji Kumar, MD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie, Inc.; Amgen, Inc.; Antengene; ArcellX; AstraZeneca Pharmaceuticals LP; BeiGene (Beijing) Co., Ltd; bluebird bio, Inc.; Bristol Myers Squibb Company; Janssen Biotech, Inc.; K36; Loxo Oncology; Oncopeptides AB; Roche-Genentech; Sanofi; Secura Biotherapeutics; Takeda; Trillium
    Research funding from: AbbVie, Inc.; Amgen, Inc.; Allogene; AstraZeneca Pharmaceuticals LP; Bristol Myers Squibb Company; CARsgen Therapeutics; GlaxoSmithKline; Janssen Biotech, Inc.; Novartis; Regeneron Pharmaceuticals, Inc.; Roche-Genentech; Takeda


  • Dragan Jevremovic, MD

    Professor of Pathology
    Division of Hematopathology
    Mayo Clinic
    Rochester, Minnesota


    Dragan Jevremovic, MD, has the following relevant financial relationships:
    Consultant or advisor for: ArcellX
    Speaker or member of speakers bureau for: AbbVie Inc.


  • Megan Whitney, DMD

    Medical Education Director, Medscape, LLC


    Megan Whitney, DMD, has no relevant financial relationships.

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements


Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

    Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Multiple Myeloma: An Expert Discussion on the Role of Cytogenetics and Minimal Residual Disease

Authors: Shaji Kumar, MD; Dragan Jevremovic, MDFaculty and Disclosures

CME / ABIM MOC Released: 5/25/2023

Valid for credit through: 5/25/2024, 11:59 PM EST


Learning Feedback Questions

Please answer these questions to complement your learning experience.

  • Print